Serum and Tissue Biomarkers in the Prognosis and Treatment of Breast Cancer

互联网2014-02-13

443

Several nuclear and membrane proteins are emerging as important markers of breast-cancer behavior. There is increasing evidence that these markers have potential therapeutic as well as prognostic value in the care of breast-cancer patients.

相关产品推荐

SIM SF Expression Medium (For SF9, SF21)(Serum free) | SIM SF 细胞培养基 (用于SF9, SF21细胞)(无血清)

￥450

Coagulation Factor III / Tissue Factor / CD142 鼠单抗 (FITC)

￥700

PIEZO1/PIEZO1蛋白Recombinant Human Piezo-type mechanosensitive ion channel component 1 (PIEZO1)重组蛋白(Membrane protein induced by beta-amyloid treatment)(Mib)(Protein FAM38A)蛋白

￥1836

NRG1,GGF,HGL,HRGA,NDF,SMDF/NRG1,GGF,HGL,HRGA,NDF,SMDF蛋白Recombinant Human Pro-neuregulin-1, membrane-bound isoform protein (NRG1) (Active)重组蛋白Pro-NRG1, ARIA, Breast cancer cell differentiation factor p45, Glial growth factor, Heregulin蛋白

￥852